
CAS 2414909-94-5
:Formula:C19H16N6O
InChI:InChI=1S/C19H16N6O/c20-18(26)15-5-3-14(4-6-15)16-12-23-25-9-7-17(24-19(16)25)22-11-13-2-1-8-21-10-13/h1-10,12H,11H2,(H2,20,26)(H,22,24)
InChI key:LMGXQBQAUALFTB-UHFFFAOYSA-N
SMILES:C1=CC(=CN=C1)CNC2=NC3=C(C=NN3C=C2)C4=CC=C(C=C4)C(=O)N
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
4-(5-((Pyridin-3-Ylmethyl)Amino)Pyrazolo[1,5-A]Pyrimidin-3-Yl)Benzamide
CAS:4-(5-((Pyridin-3-Ylmethyl)Amino)Pyrazolo[1,5-A]Pyrimidin-3-Yl)BenzamideFormula:C19H16N6OPurity:>98%Molecular weight:344.374-[5-(3-Pyridylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide
CAS:Formula:C19H16N6OPurity:98%Color and Shape:SolidMolecular weight:344.3699RET V804M-IN-1
CAS:4-(5-((Pyridin-3-ylmethyl)amino)pyrazolo[1,5-a]pyrimidin-3-yl)benzamideFormula:C19H16N6OPurity:98+%Molecular weight:344.37RET V804M-IN-1
CAS:RET V804M-IN-1 (RETV804M kinase inhibitor) is a wt-RET -selective RETV804M kinase inhibitors(IC50 = 20 nM).Formula:C19H16N6OPurity:97.94% - 99.62%Color and Shape:White SolidMolecular weight:344.3699RET V804M-IN-1
CAS:Selective inhibitor of the mutated RET variant RETV804M, which is the anticipated drug-resistant RET mutant that can occur in tumours treated with kinase inhibitors. The compound has a biochemical IC50 of 0.02 µM and selectivity for purified RETV804M over purified RET and KDR of 3.7 and 110, respectively. The efficacy of the compound was shown also in cell cultures with IC50 of 4.4 µM, and cell assay selectivity for RETV804M over RET and KDR of 0.89 and 2.3, respectively.
Formula:C19H16N6OPurity:Min. 97 Area-%Color and Shape:White PowderMolecular weight:344.37 g/mol4-(5-((PYRIDIN-3-YLMETHYL)AMINO)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)BENZAMIDE
CAS:Purity:98+%Molecular weight:344.3779907





